29th January, 2025 | By Ankit Kankar | ankit.kankar@mmactiv.com
Dr. Mohan Yadav discusses strategic investment opportunities with A&D Medical, highlighting Madhya Pradesh’s business-friendly policies, infrastructure incentives, and vision for advancing life sciences manufacturing in India.
Dr. Mohan Yadav, Hon’ble Chief Minister of Madhya Pradesh, India, held high-level discussions with Mr. Daiki Arai, Director of A&D Medical, at the Imperial Hotel in Tokyo. The meeting, held on the second day of Dr. Yadav’s official visit to Japan, focused on exploring investment opportunities in Ujjain’s 75-acre Medical Device and Pharmaceutical Park—a strategically planned industrial hub aimed at fostering innovation and manufacturing in the life sciences sector.
During the discussion, Dr. Yadav highlighted the business-friendly policies and infrastructure incentives offered by the Madhya Pradesh government to facilitate large-scale investments in medical device and pharmaceutical manufacturing. He emphasized that the state is offering highly subsidized prime land, policy relaxations, and an expedited regulatory framework for global companies looking to establish manufacturing facilities in the region.
“Madhya Pradesh is rapidly emerging as a preferred destination for life sciences innovation and healthcare manufacturing. Our Medical Device & Pharma Park in Ujjain provides world-class infrastructure, seamless connectivity, and a pro-business regulatory framework, making it an ideal choice for companies looking to expand in India’s booming healthcare market,” said Dr. Mohan Yadav.
The Ujjain Medical Device & Pharmaceutical Park is designed to cater to the growing global demand for high-quality, cost-effective medical technologies. By positioning itself as a leading hub for MedTech innovation, Madhya Pradesh offers a strategic advantage for Japanese and international manufacturers seeking to expand their footprint in India and beyond.
The Chief Minister’s visit aligns with Madhya Pradesh’s broader efforts to attract foreign direct investment (FDI) and strengthen international collaborations in the healthcare sector. The discussions with A&D Medical represent a step forward in forging business partnerships between India and Japan’s thriving MedTech and pharma industries.
Madhya Pradesh is committed to fostering a robust ecosystem for medical and pharmaceutical companies by offering:
✅ Strategic Location & Connectivity – Well-connected transport infrastructure for seamless logistics
✅ Investor-Friendly Policies – Subsidized land allocation and tax benefits for healthcare manufacturing units
✅ Skilled Workforce & R&D Support – Access to talent and academic institutions for innovation-driven growth
✅ Regulatory Ease – Streamlined approvals for rapid business setup and expansion
The meeting signals a new chapter in India-Japan trade relations, opening doors for Japanese MedTech companies to leverage India’s healthcare manufacturing capabilities and growing domestic demand.
Medtech Special
Artificial Intelligence Breakthroughs
Robots In Medtech
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer